Form 4: Blueprint Medicines Executive Sells Shares to Cover Tax Obligations

Philina Lee, Chief Commercial Officer of Blueprint Medicines, sold 2,934 shares of common stock at $90.69 to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 7, 2024, Philina Lee, the Chief Commercial Officer of Blueprint Medicines Corp, sold 2,934 shares of common stock.
• The sale was executed at a price of $90.69 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Lee directly owns 41,005 shares of Blueprint Medicines Corp.
• The sale was not a discretionary trade but an automatic 'sell to cover' transaction to satisfy tax obligations.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the transaction is related to tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company. The power of attorney is a standard legal document.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact as it was to cover tax obligations.

Key Dates